Pisarenko O I, Lakomkin V L, Studneva I M, Timoshin A A, Kuzmin A I, Ruuge E K, Kapelko V I
Institute of Experimental Cardiology, Academy of Medical Sciences, Moscow, Russia.
Biochem Med Metab Biol. 1994 Feb;51(1):16-26. doi: 10.1006/bmmb.1994.1002.
The effects of allopurinol (AP) on functional and metabolic recovery of the isolated rat heart after global ischemia were studied. Hearts were subjected to aerobic perfusion (30 min), cardioplegic infusion (5 min), normothermic ischemia (37 min), and reperfusion (50 min) which was started with secondary cardioplegic infusion (10 min). AP was injected into rats (44 mg/kg body wt ip 2 h before heart excision) and added to cardioplegic solution (2 mM) prior and after ischemia. AP treatment significantly improved postischemic recovery of the function and reduced the leakage of lactate dehydrogenase from reperfused hearts. These beneficial effects were accompanied by a better preservation of tissue content of ATP, the total adenine nucleotides, phosphocreatine, and the total creatine at the end of reperfusion. Inhibition of xanthine oxidase by AP substantially decreased pre- and postischemic release of xanthine and uric acid and increased postischemic release of hypoxanthine into the coronary effluent. Despite this, AP-treated hearts did not exhibit a reduction in hydroxyl radical adduct formation in the effluents at reperfusion assessed by the spin-trap measurements. The results suggest that AP may protect the heart from ischemia/reperfusion injury due to enhanced energy provision rather than by prevention of oxygen-derived free radical formation.
研究了别嘌醇(AP)对离体大鼠心脏在全心缺血后功能和代谢恢复的影响。心脏先进行有氧灌注(30分钟)、心脏停搏液输注(5分钟)、常温缺血(37分钟),然后开始再灌注(50分钟),再灌注从二次心脏停搏液输注(10分钟)开始。在心脏切除前2小时给大鼠腹腔注射AP(44毫克/千克体重),并在缺血前后将其加入心脏停搏液(2毫摩尔)中。AP治疗显著改善了缺血后心脏功能的恢复,并减少了再灌注心脏中乳酸脱氢酶的泄漏。这些有益作用伴随着再灌注结束时ATP、总腺嘌呤核苷酸、磷酸肌酸和总肌酸组织含量的更好保存。AP对黄嘌呤氧化酶的抑制作用显著降低了缺血前后黄嘌呤和尿酸的释放,并增加了缺血后次黄嘌呤向冠状动脉流出液中的释放。尽管如此,通过自旋捕获测量评估,AP处理的心脏在再灌注时流出液中羟基自由基加合物的形成并没有减少。结果表明,AP可能通过增强能量供应而非通过预防氧衍生自由基的形成来保护心脏免受缺血/再灌注损伤。